Literature DB >> 22173243

Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor β chain and KIT V654A.

M S Spector, I Iossifov, A Kritharis, C He, J E Kolitz, S W Lowe, S L Allen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22173243      PMCID： PMC3368985          DOI： 10.1038/leu.2011.354

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis.

Authors:  Todd M Wilson; Irina Maric; Olga Simakova; Yun Bai; Eunice Ching Chan; Nicolas Olivares; Melody Carter; Dragan Maric; Jamie Robyn; Dean D Metcalfe
Journal:  Haematologica       Date:  2010-12-06       Impact factor: 9.941

2.  The colorectal microRNAome.

Authors:  Jordan M Cummins; Yiping He; Rebecca J Leary; Ray Pagliarini; Luis A Diaz; Tobias Sjoblom; Omer Barad; Zvi Bentwich; Anna E Szafranska; Emmanuel Labourier; Christopher K Raymond; Brian S Roberts; Hartmut Juhl; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

Review 3.  Integrated signalling pathways for mast-cell activation.

Authors:  Alasdair M Gilfillan; Christine Tkaczyk
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

4.  Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis.

Authors:  Karin Hartmann; Eva Wardelmann; Yongsheng Ma; Sabine Merkelbach-Bruse; Liane M Preussner; Carla Woolery; Stephan E Baldus; Thomas Heinicke; Juergen Thiele; Reinhard Buettner; B Jack Longley
Journal:  Gastroenterology       Date:  2005-09       Impact factor: 22.682

Review 5.  Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Authors:  P Valent; H P Horny; L Escribano; B J Longley; C Y Li; L B Schwartz; G Marone; R Nuñez; C Akin; K Sotlar; W R Sperr; K Wolff; R D Brunning; R M Parwaresch; K F Austen; K Lennert; D D Metcalfe; J W Vardiman; J M Bennett
Journal:  Leuk Res       Date:  2001-07       Impact factor: 3.156

6.  Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates.

Authors:  A Tefferi; R L Levine; K-H Lim; O Abdel-Wahab; T L Lasho; J Patel; C M Finke; A Mullally; C-Y Li; A Pardanani; D G Gilliland
Journal:  Leukemia       Date:  2009-03-05       Impact factor: 11.528

7.  Competing functions encoded in the allergy-associated F(c)epsilonRIbeta gene.

Authors:  Emmanuel Donnadieu; Marie-Hélène Jouvin; Shalini Rana; Miriam F Moffatt; Ester H Mockford; William O Cookson; Jean-Pierre Kinet
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

8.  Proteomic and genetic approaches identify Syk as an AML target.

Authors:  Cynthia K Hahn; Jacob E Berchuck; Kenneth N Ross; Rose M Kakoza; Karl Clauser; Anna C Schinzel; Linda Ross; Ilene Galinsky; Tina N Davis; Serena J Silver; David E Root; Richard M Stone; Daniel J DeAngelo; Martin Carroll; William C Hahn; Steven A Carr; Todd R Golub; Andrew L Kung; Kimberly Stegmaier
Journal:  Cancer Cell       Date:  2009-10-06       Impact factor: 31.743

9.  A family of human microRNA genes from miniature inverted-repeat transposable elements.

Authors:  Jittima Piriyapongsa; I King Jordan
Journal:  PLoS One       Date:  2007-02-14       Impact factor: 3.240

10.  Resistance to c-KIT kinase inhibitors conferred by V654A mutation.

Authors:  Kathryn G Roberts; Adam F Odell; Ellen M Byrnes; Rosa M Baleato; Renate Griffith; Alan Bruce Lyons; Leonie K Ashman
Journal:  Mol Cancer Ther       Date:  2007-03       Impact factor: 6.261
View more
  11 in total

Review 1.  Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.

Authors:  P Valent; K Sotlar; W R Sperr; L Escribano; S Yavuz; A Reiter; T I George; H C Kluin-Nelemans; O Hermine; J H Butterfield; H Hägglund; C Ustun; J L Hornick; M Triggiani; D Radia; C Akin; K Hartmann; J Gotlib; L B Schwartz; S Verstovsek; A Orfao; D D Metcalfe; M Arock; H-P Horny
Journal:  Ann Oncol       Date:  2014-03-27       Impact factor: 32.976

Review 2.  Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis.

Authors:  Oscar González-López; Javier I Muñoz-González; Alberto Orfao; Iván Álvarez-Twose; Andrés C García-Montero
Journal:  Cancers (Basel)       Date:  2022-05-18       Impact factor: 6.575

3.  Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology.

Authors:  Peter Valent
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

4.  Application of next generation sequencing in the diagnosis and management of mast cell leukemia.

Authors:  Juwon Kim
Journal:  Blood Res       Date:  2016-03-25

5.  A scientific treatment approach for acute mast cell leukemia: using a strategy based on next-generation sequencing data.

Authors:  Jeonghwan Youk; Youngil Koh; Ji-Won Kim; Dae-Yoon Kim; Hyunkyung Park; Woo June Jung; Kwang-Sung Ahn; Hongseok Yun; Inho Park; Choong-Hyun Sun; Seungmook Lee; Sung-Soo Yoon
Journal:  Blood Res       Date:  2016-03-25

6.  SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis.

Authors:  G Martinelli; M Mancini; C De Benedittis; M Rondoni; C Papayannidis; M Manfrini; M Meggendorfer; R Calogero; V Guadagnuolo; M C Fontana; L Bavaro; A Padella; E Zago; L Pagano; R Zanotti; L Scaffidi; G Specchia; F Albano; S Merante; C Elena; P Savini; D Gangemi; P Tosi; F Ciceri; G Poletti; L Riccioni; F Morigi; M Delledonne; T Haferlach; M Cavo; P Valent; S Soverini
Journal:  Leukemia       Date:  2017-06-16       Impact factor: 11.528

7.  KIT D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid Leukemia.

Authors:  Marta Lopes; Maria Dos Anjos Teixeira; Cláudia Casais; Vanessa Mesquita; Patrícia Seabra; Renata Cabral; José Palla-García; Catarina Lau; João Rodrigues; Maria Jara-Acevedo; Inês Freitas; Jose Ramón Vizcaíno; Jorge Coutinho; Luis Escribano; Alberto Orfao; Margarida Lima
Journal:  Case Rep Hematol       Date:  2018-02-18

Review 8.  Systemic Mastocytosis: Molecular Landscape and Implications for Treatment.

Authors:  Cecilia Monaldi; Sara De Santis; Manuela Mancini; Samantha Bruno; Michele Cavo; Simona Soverini
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-07-01       Impact factor: 2.576

9.  Familial occurrence of systemic mast cell activation disease.

Authors:  Gerhard J Molderings; Britta Haenisch; Manuela Bogdanow; Rolf Fimmers; Markus M Nöthen
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

10.  A survey of tools for variant analysis of next-generation genome sequencing data.

Authors:  Stephan Pabinger; Andreas Dander; Maria Fischer; Rene Snajder; Michael Sperk; Mirjana Efremova; Birgit Krabichler; Michael R Speicher; Johannes Zschocke; Zlatko Trajanoski
Journal:  Brief Bioinform       Date:  2013-01-21       Impact factor: 11.622
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.